Skip to content
Toggle navigation
About Us
Overview
Leadership Team
Board of Directors
Science & Platform
What is Immune Tolerance?
Our Approach
Pipeline
Overview
SynCeD
ACeD-it | Celiac Disease
ACeD | Celiac Disease
MoveS-it | Multiple Sclerosis
Investors & Media
Overview
Press Releases
Publications
In the News
Careers
Contact
About Us
Overview
Leadership Team
Board of Directors
Science & Platform
What is Immune Tolerance?
Our Approach
Pipeline
Overview
SynCeD
ACeD-it | Celiac Disease
ACeD | Celiac Disease
MoveS-it | Multiple Sclerosis
Investors & Media
Overview
Press Releases
Publications
In the News
Careers
Contact
Terms of Use
Privacy: US
Privacy: EU/UK
Site Credits
Investors & Media
Publications
Publications
Publications
2019
2023
2019
2015
2012
September 13, 2019
Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress
VIEW POSTER